Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Classical hematology 1

Conditions

Thrombocytopenia 1Stomach Neoplasms 1Neutropenia 1Neoplasms, Plasma Cell 1Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Appendiceal Neoplasms 1

Interventions

pegylated granulocyte colony-stimulating factor 1ceftolozane, tazobactam drug combination 1Vitamin B 12 1Vancomycin 1Transplantation 1Piperacillin, Tazobactam Drug Combination 1Peripheral Blood Stem Cell Transplantation 1Moxifloxacin 1Loratadine 1Folic Acid 1Daptomycin 1Cloxacillin 1Ciprofloxacin 1Caspofungin 1Amoxicillin-Potassium Clavulanate Combination 1Amikacin 1Algorithms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Neutropenia × Algorithms × Clear all
NCT04526886 2025-10-06

Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy

Dartmouth-Hitchcock Medical Center

Phase NA Completed
52 enrolled 8 charts
Classical hematologyGastrointestinal

Appendiceal Neoplasms, Esophageal Neoplasms, Neutropenia, Stomach Neoplasms, Thrombocytopenia, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡